Related Experiment Video
Updated: Jan 8, 2026

09:58
A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid
Published on: January 31, 2012
21.2K
Cartilage organoids from basic research to clinical translation
Wenyi Zhang1,2, Lin Chen1,2, Yuzhen Li2
1Department of Rehabilitation, Shengjing Hospital of China Medical University, No.16 Puhe Road, Shenbei New District, Shenyang, Liaoning Province, China.
Iscience
|December 24, 2025
Summary
Cartilage organoids (COs) advance joint repair research by mimicking native tissue and disease states. These 3D models offer powerful tools for studying osteoarthritis and developing personalized tissue engineering strategies.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Tissue Engineering
Background:
- Cartilage organoids (COs) are advanced 3D models overcoming limitations of traditional 2D cell cultures.
- COs preserve chondrocyte phenotype and metabolic function, crucial for cartilage research.
- They effectively model pathological microenvironments, such as osteoarthritis.
Purpose of the Study:
- To review recent advancements in cartilage organoid technology.
- To assess the translational potential of COs in biomedical applications.
- To identify challenges and future research directions in the field.
Main Methods:
- Synthesis of recent literature on cartilage organoids.
- Critical assessment of COs for disease modeling and drug screening.
- Evaluation of CO integration with microfluidics, bioprinting, and mechanical loading.
Main Results:
- COs offer a superior model for studying cartilage biology and diseases like osteoarthritis.
- Integration with advanced technologies enhances their potential for personalized tissue engineering.
- Significant progress has been made in developing and applying COs.
Conclusions:
- Cartilage organoids are a promising tool for joint repair and tissue regeneration research.
- Further research is needed to overcome challenges and realize their full translational promise.
- COs hold potential for personalized medicine and therapeutic agent screening.

